Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Discovery Labs Surges as FDA Agrees to Updated Surfaxin Specifications

By  +Follow October 4, 2013 2:07AM
Tickers Mentioned:

Shares of Discovery Laboratories, Inc. (DSCO) leapt forward immediately in Friday trading after the U.S. Food and Drug Administration agreed to updated product specifications for Surfaxin® Intratracheal Suspension, the company’s approved drug for the prevention of respiratory distress syndrome, or RDS, in premature infants at high risk for RDS. Surfaxin is the first synthetic, peptide-containing surfactant approved by the FDA and the only alternative to animal-derived surfactants. 

A surfactants is a liquid that coats the inside of the lungs and helps to keep them open.  Premature infants are not able to produce enough surfactant, resulting in lungs collapsing and the infant having difficulty breathing.

Other surfactants on the market are Survanta (beractant), Infasurf (calfactant) and Cornerstone Therapeutics’ (CRTX) Curosurf (poractant alpha), but, as mentioned, these drugs are derived from animals. Curosurf sales in the second quarter were $11.3 million, its best quarter on record. Italy’s Chiesi Farmaceutici, which already owns 58 percent of Cornerstone, agreed in September to pay $115 million for the remaining stake in the company that it didn’t already own to take it private.

In March 2012, the FDA approved Surfaxin for RDS and the drug was expected to be launched in the fourth quarter of 2013, but Discovery determined through a routine review that one of its analytical chemistry methods used to assess the performance of Surfaxin required improvement, delaying the launch by two quarters. 

Then in April, Warrington, Pennsylvania-based Discovery disclosed that the FDA requested more information on product specifications of Surfaxin, further delaying the launch and sending shares of DSCO plunging about 40 percent to lows of $1.50.

Discovery has now met the demands of the FDA that have plagued product launch. The company has initiated manufacturing of Surfaxin for its planned commercial introduction in the fourth quarter of 2013.

"We are pleased that the FDA has agreed with our updated product specifications and are appreciative of the process that has lead to this decision," said John G. Cooper, chief executive of Discovery in a statement today. "Surfaxin represents the first milestone in our goal of transforming the treatment of RDS and is an important medical advancement for the neonatology community and parents of preterm infants who will soon have an effective alternative to animal-derived surfactants for the prevention of RDS."

Shares of DSCO drove north of $3.00 shortly after Friday’s opening from Thursday’s closing price of $1.97, but have cooled off to $2.75 1-1/2 hours into the trading session for gains of around 40 percent.  Through Thursday’s close, shares were down about 6 percent in 2013, but have reversed the losses with today’s climb

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Signup for our daily newsletter and get our best articles emailed right to you!

Results for dsco
Seeking Alpha Alerts
26 Mar 15 18:41:12
@tj2222000 Subscribed to $DSCO To add another, tweet: $SYMBOL @sa_alerts To unsubscribe: unsubscribe $SYMBOL @sa_alerts
26 Mar 15 18:40:20
@sa_alerts $JAZZ $DSCO
Daily Contracts
26 Mar 15 10:35:01
Real-Time feed of company contracts, original agreements and executive updates from $DSCO http://t.co/XbwrOjA3e2
26 Mar 15 09:03:29
sold remaining $flml and $dsco shares. My bet is @MartinShkreli finds a way to merge $DSCO for his new firm and unlock its full potential
26 Mar 15 02:15:28
Nice opportunity to start scaling in into some interesting Bio Stocks over the coming few 4 weeks ...$IDRA $ZIOP $SNSS $DSCO $ATHX
Thomas Collins
25 Mar 15 13:05:16
$DSCO Discovery Labs Reports Fourth Quarter 2014 Financial Results and Provides ... http://t.co/F22jLzeggV
James P Worthy
25 Mar 15 13:05:12
$DSCO Discovery Laboratories Latest Stock Surge Intriguing (DSCO) http://t.co/oxgKxIYSr4
Capital Market Labs
25 Mar 15 10:59:12
$GNCA, $MCUR, $ARQL, $NBS, $DSCO Cash from Operations Trend Comparison http://t.co/n0L0igdbXK https://t.co/O7J0gCDLXd
Penny Stock Secret
25 Mar 15 04:45:06
Yesterday We Made $94,000 In Just One Trade More Info Here http://t.co/NovWYe2RAx .. $DSCO $NBS $VRTU
24 Mar 15 15:27:09
Bullish Engulfing http://t.co/DwAI7bkOeA $EGT $EPV $CHI $AIR $DSCO $PODD $STEM $WG $ADSK $MTSN $SBUX $AMRN
24 Mar 15 08:46:15
$DSCO 2%
Large Void Bot
24 Mar 15 08:31:11
Daily Reversal (11:31): $DSCO Last: 1.24; pHigh: 1.24; rVol: 0.331; pClose: 1.22; LOD: 1.2200; Perf: 1.6%
Jet Life PennyStock$
24 Mar 15 03:24:15
DollarsOnPennies: $DSCO Gallery View http://t.co/yTpUgMrPnU
HotStockAlert $PKGM$
24 Mar 15 03:14:52
DollarsOnPennies: $DSCO Gallery View http://t.co/J7IDaWO0sv
24 Mar 15 03:14:44
DollarsOnPennies: $DSCO Gallery View http://t.co/5F3Q9LHVtN
24 Mar 15 03:13:50
http://t.co/aZJZ3xCtiA DollarsOnPennies: $DSCO Gallery View: DollarsOnPennies http://t.co/nejJnxnQ9B http://t.co/L30DTMhSl8 $BICX
Capital Market Labs
24 Mar 15 00:44:09
$GNCA, $MCUR, $ARQL, $NBS, $DSCO Cash from Operations Trend Comparison http://t.co/n0L0igdbXK https://t.co/O7J0gCDLXd
Daily Contracts
23 Mar 15 12:04:01
Real-Time feed of company contracts, original agreements and executive updates from $DSCO http://t.co/XbwrOjA3e2
WallStreet Pennies
23 Mar 15 03:43:38
DollarsOnPennies: $DSCO Gallery View http://t.co/kvTagMnk3d
23 Mar 15 03:32:15
DollarsOnPennies: $DSCO Gallery View http://t.co/3Vqmr2308P
21 Mar 15 02:13:25
$DSCO Piper Jaffray Reaffirms “Overweight” Rating for Discovery Laboratories http://t.co/u5FmBHUWcs
Stocks News&Markets
20 Mar 15 12:50:14
$VGGL up 14.49% today! Check out this trade http://t.co/E6jeWO7xwL I made 12.50% on $DSCO JOIN US LIVE: http://t.co/EQWvokRIdO
By  +Follow October 4, 2013 2:07AM



blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.